Found 5 matching trials
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) PHASE3 This is a 16-week, multicenter, randomized, parallel-group, double-blind, c...
Show More Location
Clinical Trial Site 15
Learn More & Join Trial
Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks PHASE1 The purpose of this trial is to evaluate the effects of 16-week treatment w...
Show More Learn More & Join Trial
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. PHASE3 This is a 16-week, multicenter, randomized, parallel-group, double-blind, c...
Show More Location
Clinical Trial Site 05
Learn More & Join Trial
A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules PHASE2 Clinical assessments of efficacy will be conducted based on Investigator's ...
Show More Learn More & Join Trial
A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects PHASE1 Single-center, randomized, open-label, laboratory-blinded, 3-treatment, 3-p...
Show More Learn More & Join Trial